Ming Zhao

发表

A prediction model of delayed graft function in deceased donor for renal transplant: a multi-center study from China

W. Xue, W. Sui, Qiquan Sun, 2021, Renal failure.

Two‐dose basiliximab compared with two‐dose daclizumab in renal transplantation: a clinical study

Minzhuan Lin, Ming Zhao, A. Ming, 2006, Clinical transplantation.

Modernization of the organ transplantation program in China.

Y. Mao, Yu Wang, Jiefu Huang, 2008, Transplantation.

Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial

N. Na, Qipeng Sun, Zheng-yu Huang, 2017, Trials.

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

N. Na, Daqiang Zhao, Fei Han, 2018, Journal of Translational Medicine.

A Multicenter Clinical Study of Single-Kidney Transplantation vs En Bloc Transplantation with Kidneys from Deceased Pediatric Donors.

Ming Zhao, Jian-min Hu, Yong Liu, 2019, Transplantation Proceedings.

Current Strategies for Engineered Vascular Grafts and Vascularized Tissue Engineering

Junyang Chen, Lingmei Wu, Ming Zhao, 2023, Polymers.

Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

N. Na, Daqiang Zhao, Fei Han, 2018, Journal of Translational Medicine.